loadpatents
Patent applications and USPTO patent grants for Purandare; Shrinivas Madhukar.The latest application filed is for "pharmaceutical compositions".
Patent | Date |
---|---|
Pharmaceutical Compositions App 20210308150 - Malhotra; Geena ;   et al. | 2021-10-07 |
Pharmaceutical compositions Grant 11,077,124 - Malhotra , et al. August 3, 2 | 2021-08-03 |
Pharmaceutical composition Grant 10,179,139 - Malhotra , et al. Ja | 2019-01-15 |
Pharmaceutical Composition Comprising Deferasirox App 20180311216 - MALHOTRA; Geena ;   et al. | 2018-11-01 |
Pharmaceutical Compositions App 20170333452 - Malhotra; Geena ;   et al. | 2017-11-23 |
Low Dose Pharmaceutical Composition App 20170312254 - MALHOTRA; Geena ;   et al. | 2017-11-02 |
Dose counter Grant 9,713,685 - Malhotra , et al. July 25, 2 | 2017-07-25 |
Low Dose Pharmaceutical Composition App 20170095453 - MALHOTRA; Geena ;   et al. | 2017-04-06 |
Pharmaceutical Composition App 20170027908 - Malhotra; Geena ;   et al. | 2017-02-02 |
Pharmaceutical Composition Comprising Deferasirox App 20160324831 - MALHOTRA; Geena ;   et al. | 2016-11-10 |
Low Dose Pharmaceutical Composition App 20160158202 - MALHOTRA; Geena ;   et al. | 2016-06-09 |
Low Dose Pharmaceutical Composition App 20160120847 - MALHOTRA; Geena ;   et al. | 2016-05-05 |
Pharmaceutical Compositions for Rectal Administration App 20160002278 - PURANDARE; Shrinivas Madhukar ;   et al. | 2016-01-07 |
Pemetrexed Complexes and Pharmaceutical Compositions Containing Pemetrexed Complexes App 20150359898 - Purandare; Shrinivas Madhukar ;   et al. | 2015-12-17 |
Topical Pharmaceutical Composition App 20150246065 - Malhotra; Geena ;   et al. | 2015-09-03 |
Fixed Dose Pharmaceutical Composition Comprising Deferasirox And Deferiprone App 20150246027 - Purandare; Shrinivas Madhukar ;   et al. | 2015-09-03 |
Pharmaceutical Antiretroviral Combinations Comprising Lamivudine, Festinavir and Nevirapine App 20150104511 - Malhotra; Geena ;   et al. | 2015-04-16 |
Antiretroviral Composition App 20150086628 - Purandare; Shrinivas Madhukar ;   et al. | 2015-03-26 |
Pharmaceutical Compositions Comprising Ebastine and Fluticasone App 20150080355 - Malhotra; Geena ;   et al. | 2015-03-19 |
Low Dose Pharmaceutical Composition Comprising Zanamivir App 20150034087 - Malhotra; Geena ;   et al. | 2015-02-05 |
Pharmaceutical Composition App 20140308214 - Malhotra; Geena ;   et al. | 2014-10-16 |
Pharmaceutical Antiretroviral Composition App 20140193491 - Malhotra; Geena ;   et al. | 2014-07-10 |
A Dose Counter App 20140150778 - Malhotra; Geena ;   et al. | 2014-06-05 |
Pharmaceutical Composition App 20140147393 - Malhorta; Geena ;   et al. | 2014-05-29 |
Pharmaceutical Composition Comprising Deferasirox App 20140147503 - Malhotra; Geena ;   et al. | 2014-05-29 |
Pharmaceutical Compositions App 20130330281 - Malhotra; Geena ;   et al. | 2013-12-12 |
Pharmaceutical Composition App 20130315988 - Purandare; Shrinivas Madhukar ;   et al. | 2013-11-28 |
Pharmaceutical Compositions App 20130274232 - Malhotra; Geena ;   et al. | 2013-10-17 |
Low Dose Pharmaceutical Composition Comprising Zanamivir App 20130251790 - Malhotra; Geena ;   et al. | 2013-09-26 |
Topical Foam Composition App 20130202654 - Lulla; Amar ;   et al. | 2013-08-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.